Effect of Different Colistin Doses on Clinical Outcome of Pediatric Cancer Patients With Gram Negative Infections

NCT03397914 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

70

Enrollment

OTHER

Sponsor class

Conditions

Gram-Negative Bacterial Infections
Pediatric Cancer
Colistin
Colistin Adverse Reaction
MIC

Interventions

DRUG: Colistimethate Sodium

Sponsor

National Cancer Institute, Egypt